Vikrant competed technical education at universities in India, Canada and United States; and his MBA from Singapore. Since joining Institute of Chemical and Engineering Sciences, A*STAR, in 2010 he has led several projects in areas such as total synthesis of natural products, medicinal chemistry, and synthetic methodology. However, development and application of novel molecular building-blocks is at the core of Vikrant’s research interest. Having explored the synthetic feasibility of selected novel motifs, Vikrant strongly believes that the technology is ripe for development of new applications, and that such approach is best launched on a commercial platform. SciClix, he believes, will provide such a platform.
Shubhangi completed her M.Sc in Organic Chemistry from India and worked as a lecturer. She then pursued her second Master’s degree at Memorial University of Newfoundland, Canada. Shubhangi’s core research interests are focused on asymmetric organocatalysis.
She has considerable experience in both management and teaching. At SciClix, Shubhangi aims to use her technical and management expertise to support and advance company’s mission and vision.
SciClix enjoys the support of several distinguished experts who function as our hands-on consultants.
Song Ning advises the Sciclix team on intellectual property (IP) and legal matters. He has worked in the private and public sectors as a Lawyer, IP Specialist, and Engineer.Click here to rotate
As a Lawyer, Song Ning has represented clients at all levels of the Singapore courts, in matters ranging from contractual disputes to pharmaceutical patent infringement. He has also negotiated, drafted, and reviewed many commercial documents, ranging from SaaS agreements, franchise agreements and data protection policies to sponsorship agreements, shareholders’ agreements, and loan agreements.
Dr. Ferrer obtained his Doctor of Philosophy from the Department of Chemistry at the University of Massachusetts Amherst under the supervision of Prof L. A. Carpino. During his doctoral studies, his main research interest was peptide coupling reagents and additives for peptide synthesis.Click here to rotate
He then worked as a Scientist at Amylin Pharmaceuticals performing peptide drug discovery for diabetes and other metabolic diseases. Followed by this, Dr. Ferrer assumed the role of the Director of a Core Peptide facility at The Burnham Institute in La Jolla, CA (now: Sanford Burnham Prebys Medical Discovery Institute) in the Erkki Ruoslahti Laboratory for the synthesis of Arg-Gly-Asp (RGD) and tumor-homing peptides.
Since 2013, Dr. Ferrer is working as a Senior Scientist, in the p53 Laboratory at A* STAR, Singapore. Here, Dr. Ferrer leads the Peptide Science efforts in the development and implementation of A*STAR’s R&D strategies. During his current appointment Dr. Ferrer, along with Sir Dr. David Lane and Prof Greg Verdine lead the Visitor Investigator Program (VIP) grant. As a result, his participation as a peptide scientist in the program, Dr. Ferrer contributed to discover very active stapled peptides that re-activate p53 protein in several types of cancers, including acute myeloid leukemia (AML). Also, he is inventor or co-inventor in several patents related to the peptide field.
Minal is an experienced user-interface and user-experience designer having more than 8 years of experience in web designing. She has delivered many projects that have met highest standards of user-experience and visual design.Click here to rotate
Minal has keen interest in web design technologies and mobile applications. Minal is responsible for designing and maintenance of SciClix website. She is continuously looking-out for creative engagements with SciClix team to improve the web experience.